Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,304 across all filing types
Latest filing 2022-02-22 Foreign Filer Report
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
CHAIR SUCCESSION PLANNING UPDATE AND ANNUAL REPORT
Foreign Filer Report
2022-02-22 English
ENHERTU IMPROVES PFS AND OS IN HER2-LOW BC
Foreign Filer Report
2022-02-22 English
Chair succession planning update and Annual Report
Board/Management Information Classification · 99% confidence The document is a regulatory announcement (RNS Number: 3462C) dated February 22, 2022. The title explicitly states two key actions: 'Update on Succession Planning for Chair of the Board' and 'Publication of Annual Financial Report'. The text confirms the publication of the 'Annual Report and Form 20-F Information 2021' and notes that a copy has been submitted to the National Storage Mechanism and will be available on the website. Since the document's primary function is to announce the availability/publication of the Annual Report, rather than being the full 10-K document itself, it fits the definition of a Report Publication Announcement (RPA). While it mentions the AGM date, the core focus is the report release announcement, making RPA more specific than AGM-R or 10-K in this context, especially given the short length and focus on 'publication'.
2022-02-22 English
AZ - 2021 ESEF Annual report-T01
Annual Report (ESEF) Classification · 100% confidence FY 2021
2022-02-22 English
AZ - 2021 ESEF Annual report-T01
Annual Report Classification · 100% confidence The document is explicitly titled 'AstraZeneca Annual Report and Form 20-F 2021'. It contains comprehensive sections including a Strategic Report, Corporate Governance, Financial Statements, and Auditor's Report, covering the full fiscal year 2021. This matches the definition of an Annual Report (10-K). FY 2021
2022-02-22 English
Annual Report 2021
Annual Report Classification · 100% confidence The document is the 'AstraZeneca Annual Report and Form 20-F Information 2021'. It contains comprehensive financial statements, management reports, governance information, and audit reports for the fiscal year 2021. It is a full annual report, not an announcement or a summary. FY 2021
2022-02-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.